Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Uscom.
RELATED STOCKHEAD STORIES
News
These ASX stocks are set to ride China’s market wave as trade relations warm
Health & Biotech
With FDA approval close, Echo IQ’s AI platform is set to disrupt US heart disease market
Health & Biotech
FDA submission looms as Artrya’s AI platform aims to capture the huge cardio diseases market
Experts
CRITERION: Cracking the China nut – it’s the GOAT challenge
Health & Biotech
ASX Health Stocks: Nova Eye faces FDA hurdle in the US, Uscom recognised in China
Health & Biotech
ASX Health Stocks: China likes Uscom device, includes it in national emergency guidelines
Health & Biotech
Here are the ASX heart stocks fighting the number one killer disease in humans
Health & Biotech
China is about to grant patents like never before, and these ASX stocks have already got some
Health & Biotech
ASX Health Stocks: USCOM jumps 12pc on China patent, while Next Science gets TGA nod
Health & Biotech
Dr Boreham’s Crucible: Breaking down the post-COVID market opportunity for Uscom
Health & Biotech
ASX health stocks: Rhinomed rockets 80% after securing first government purchase for COVID-19 Rhinoswabs
News
Last Orders: ASX returns to the green, gaining 0.78 per cent
News
Last Orders: ASX jogs out of the blocks to start the week
Health & Biotech
Heart disease is becoming a bigger problem but these ASX stocks are trying to help with it
Health & Biotech
These four ASX companies are primed to benefit as China accelerates out of COVID-19
Health & Biotech
ASX asthma stocks: Global Health becomes the latest contender
News
